Valley Wealth Managers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.7M | Sell |
48,689
-795
| -2% | -$354K | 1.56% | 24 |
|
2025
Q1 | $24M | Sell |
49,484
-1,040
| -2% | -$504K | 1.82% | 14 |
|
2024
Q4 | $20.3M | Buy |
50,524
+50
| +0.1% | +$20.1K | 1.52% | 24 |
|
2024
Q3 | $23.5M | Sell |
50,474
-1,006
| -2% | -$468K | 1.74% | 11 |
|
2024
Q2 | $24.1M | Sell |
51,480
-3,723
| -7% | -$1.75M | 1.92% | 8 |
|
2024
Q1 | $23.1M | Sell |
55,203
-4,093
| -7% | -$1.71M | 1.74% | 13 |
|
2023
Q4 | $24.1M | Sell |
59,296
-1,600
| -3% | -$651K | 1.88% | 8 |
|
2023
Q3 | $21.2M | Sell |
60,896
-3,170
| -5% | -$1.1M | 1.77% | 11 |
|
2023
Q2 | $22.5M | Sell |
64,066
-4,268
| -6% | -$1.5M | 2.02% | 10 |
|
2023
Q1 | $21.5M | Sell |
68,334
-3,913
| -5% | -$1.23M | 1.96% | 11 |
|
2022
Q4 | $20.9M | Sell |
72,247
-6,879
| -9% | -$1.99M | 1.94% | 14 |
|
2022
Q3 | $22.9M | Sell |
79,126
-6,699
| -8% | -$1.94M | 2.29% | 3 |
|
2022
Q2 | $24.2M | Sell |
85,825
-4,678
| -5% | -$1.32M | 2.26% | 4 |
|
2022
Q1 | $23.6M | Sell |
90,503
-4,735
| -5% | -$1.24M | 1.97% | 11 |
|
2021
Q4 | $20.9M | Sell |
95,238
-1,125
| -1% | -$247K | 1.68% | 19 |
|
2021
Q3 | $17.5M | Buy |
+96,363
| New | +$17.5M | 1.52% | 31 |
|
2017
Q1 | – | Sell |
-32
| Closed | -$2K | – | 247 |
|
2016
Q4 | $2K | Buy |
+32
| New | +$2K | ﹤0.01% | 231 |
|